Temuterkib (LY3214996) is a selective, novel erK1/2 inhibitor with an IC50 of 5 nM against ERK1 and ERK2. It can effectively inhibit intracellular P-RSK1 in cancer cell lines with BRAF and RAS mutations. Temuterkib has strong antitumor activity in cancer
Molecular Weight:
453.56
Purity:
99.52%
CAS Number:
[1951483-29-6]
Formula:
C22H27N7O2S
Target:
ERK
* VAT and and shipping costs not included. Errors and price changes excepted